SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$13.3B
1-Year Return
26.83%
This Quarter Return
-0.7%
1 Year Return
+26.83%
3 Year Return
+97.05%
5 Year Return
+189.63%
10 Year Return
–
AUM
$12.9B
AUM Growth
+$187M
(+1.5%)
Cap. Flow
+$430M
Cap. Flow
% of AUM
3.33%
Top 10 Holdings %
Top 10 Hldgs %
20.89%
Holding
2,455
New
620
Increased
592
Reduced
680
Closed
495
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 2 |
iShares MSCI India ETF
INDA
|
+$132M |
| 3 |
Apple
AAPL
|
+$79.6M |
| 4 |
C.H. Robinson
CHRW
|
+$78.4M |
| 5 |
CSX Corp
CSX
|
+$72.7M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$783M |
| 2 |
United Airlines
UAL
|
+$84.8M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$77.2M |
| 4 |
FedEx
FDX
|
+$71.5M |
| 5 |
Amazon
AMZN
|
+$70M |
Sector Composition
| 1 | Industrials | 17.28% |
| 2 | Technology | 14.28% |
| 3 | Consumer Discretionary | 10.33% |
| 4 | Healthcare | 8.43% |
| 5 | Financials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
PharmaCyte Biotech
PMCB
$6.86M
| $46.5K | ﹤0.01% |
23,700
+200
| +0.9% | +$392 |
|
|
OPI
1802
Office Properties Income Trust
OPI
$18.7M
| $45.9K | ﹤0.01% |
+22,500
| New | +$45.9K |
|
1803
AC Immune
ACIU
$241M
| $45.5K | ﹤0.01% |
+11,400
| New | +$45.5K |
|
1804
BioAtla
BCAB
$39.2M
| $45.5K | ﹤0.01% |
+33,200
| New | +$45.5K |
|
1805
Citius Pharmaceuticals
CTXR
$20.6M
| $45.3K | ﹤0.01% |
+3,104
| New | +$45.3K |
|
|
BIG
1806
DELISTED
Big Lots, Inc.
BIG
| $45.2K | ﹤0.01% |
+26,100
| New | +$45.2K |
|
1807
PDS Biotechnology
PDSB
$57.8M
| $45.1K | ﹤0.01% |
+15,400
| New | +$45.1K |
|
1808
FibroGen
FGEN
$46.5M
| $43.9K | ﹤0.01% |
1,968
+388
| +25% | +$8.66K |
|
1809
NextCure
NXTC
$14.7M
| $43.9K | ﹤0.01% |
2,300
-30,470
| -93% | -$581K |
|
1810
reAlpha
AIRE
$58.6M
| $43.5K | ﹤0.01% |
45,800
-7,100
| -13% | -$6.75K |
|
1811
Seres Therapeutics
MCRB
$154M
| $43.5K | ﹤0.01% |
+3,005
| New | +$43.5K |
|
|
AACG
1812
ATA Creativity
AACG
$67M
| $42K | ﹤0.01% |
51,400
-100
| -0.2% | -$82 |
|
|
HKD
1813
AMTD Digital
HKD
$575M
| $41.5K | ﹤0.01% |
11,500
-2,400
| -17% | -$8.66K |
|
1814
Amylyx Pharmaceuticals
AMLX
$1.05B
| $41K | ﹤0.01% |
+21,600
| New | +$41K |
|
1815
Ohmyhome Limited Class A Ordinary Shares
OMH
$33.5M
| $41K | ﹤0.01% |
7,280
-1,730
| -19% | -$9.74K |
|
1816
Allogene Therapeutics
ALLO
$246M
| $40.1K | ﹤0.01% |
+17,192
| New | +$40.1K |
|
1817
Oxbridge Re Holdings
OXBR
$17.3M
| $40K | ﹤0.01% |
16,800
-200
| -1% | -$476 |
|
1818
Origin Materials
ORGN
$80.2M
| $39.3K | ﹤0.01% |
+43,600
| New | +$39.3K |
|
1819
Aclaris Therapeutics
ACRS
$221M
| $38.8K | ﹤0.01% |
+35,300
| New | +$38.8K |
|
1820
Research Frontiers
REFR
$43.4M
| $38.5K | ﹤0.01% |
20,900
-1,100
| -5% | -$2.02K |
|
|
VTNR
1821
DELISTED
Vertex Energy, Inc
VTNR
| $38.2K | ﹤0.01% |
+40,400
| New | +$38.2K |
|
1822
Veritone
VERI
$201M
| $38K | ﹤0.01% |
+16,800
| New | +$38K |
|
|
ASLN
1823
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $37.3K | ﹤0.01% |
15,538
-2,887
| -16% | -$6.93K |
|
1824
Microvast
MVST
$913M
| $37.3K | ﹤0.01% |
+81,700
| New | +$37.3K |
|
|
XELA
1825
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $36.9K | ﹤0.01% |
15,200
-300
| -2% | -$729 |
|